Prichard Heather's most recent trade in Humacyte Inc was a trade of 283,101 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 283,101 | 283,101 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 525 | 2,625 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share. | 30 May 2024 | 78,779 | 81,404 | - | 2.6 | 201,674 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.36 per share. | 30 May 2024 | 78,779 | 2,625 | - | 8.4 | 658,592 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 78,779 | 0 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.71 per share. | 30 May 2024 | 61,941 | 2,625 | - | 7.7 | 477,565 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.32 per share. | 30 May 2024 | 48,166 | 2,625 | - | 8.3 | 400,741 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 30 May 2024 | 48,166 | 50,791 | - | 3.1 | 147,870 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 48,166 | 87,834 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 30 May 2024 | 2,625 | 0 | - | 9.4 | 24,707 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 290,000 | 290,000 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Prichard Heather | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 525 | 2,100 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 64,990 | 0 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 24 May 2023 | 64,990 | 74,179 | - | 1.2 | 77,338 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 24 May 2023 | 13,789 | 22,978 | - | 1.2 | 16,409 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 24 May 2023 | 13,789 | 9,189 | - | 4.1 | 57,086 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 13,789 | 64,990 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.83 per share. | 24 May 2023 | 9,613 | 64,566 | - | 3.8 | 36,818 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 6,564 | 0 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share. | 12 Dec 2022 | 6,564 | 9,189 | - | 1.2 | 7,549 | Common Stock |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 136,000 | 136,000 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 157,558 | 157,558 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 78,779 | 78,779 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 78,779 | 78,779 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 6,564 | 6,564 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 2,625 | 2,625 | - | - | Common Stock | |
Humacyte Inc | Heather Prichard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,575 | 1,575 | - | - | Stock Options (right to buy) |